205752-03-0

Upstream product

• 35947-40-1 4-(3-methoxy-phenyl)-2-(4-methoxy-phenyl)-4-oxo-butyric acid 
• 130820-51-8 (2E)-1-(3-methoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one 
• 104-01-8 4-Methoxyphenylacetic acid 
• 2146-61-4 3-methoxyphenethyl bromide 
• 857544-02-6 4-(3-methoxy-phenyl)-2-(4-methoxy-phenyl)-4-oxo-butyric acid amide 
• 855750-45-7 4-(3-methoxy-phenyl)-2-(4-methoxy-phenyl)-4-oxo-butyronitrile 
• 623-11-0 1-methyl-4-nitrosobenzene 

Downstream Products

• 96034-06-9 6-methoxy-2-(p-methoxyphenyl)-3,4-dihydronaphthalen-1(2H)-one 

Relevant academic research and scientific papers

2-aryl-3-aminoaryloxynaphthy1 compounds, intermediates, compositions and methods

The present invention provides a compound of formula I: STR1 or a pharmaceutically acceptable salt or solvate thereof; having activity as a selective estrogen receptor modulator, pharmaceutical compositions containing a compound of formula I, and methods

Naphthyl compounds and compositions, as estrogen receptor binding agents

The invention provides a compound of formula I: STR1 or a pharmaceutically acceptable salt or solvate thereof; pharmaceutical compositions containing a compound of formula I, and methods of using a compound of formula I for inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions including hyperlipidemia, and estrogen dependent cancer.

1-Aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods

The present invention provides a class of compounds having the structure or a pharmaceutically acceptable salt where R1is hydrogen, hydroxy, alkoxy, alkoxycarbonyl, alkoxycarbonyloxy, aryloxycarbonyl, phenoxycarbonyloxy, or alkylsulfonyloxy; R

2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods

The present invention provides pharmaceutically active compounds formula I or a pharmaceutically acceptable salt or solvate thereof having activity as selective estrogen receptor modulators, pharmaceutical compositions containing the compounds, an

Naphthyl compounds, compositions, and methods

The invention provides naphthyl compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions including hyperlipidemia, and estrogen-dependent cancer.